When.com Web Search

  1. Ads

    related to: how to challenge patent re examination in california dmv form 14 r11 1

Search results

  1. Results From The WOW.Com Content Network
  2. Patent opposition proceedings - Wikipedia

    en.wikipedia.org/wiki/Patent_opposition_proceedings

    Pre-grant opposition proceedings typically commence after the patent application has been published but before the substantive examination is completed by patent examiners. In some jurisdictions, the opposition period starts after a positive examination result, where the patent office indicates an intention to grant the patent. [1]

  3. Inter partes review - Wikipedia

    en.wikipedia.org/wiki/Inter_partes_review

    One may still issue a patent challenge in a District Court, rather than request an inter partes review. [6] As of mid-2017, over a thousand patents have been cancelled as a result of the inter partes review process, and there were more inter partes review cases heard through mid-2017 compared to any individual circuit court. [6]

  4. Opposition proceeding - Wikipedia

    en.wikipedia.org/wiki/Opposition_proceeding

    An opposition proceeding is an administrative process available under the patent and trademark law of many jurisdictions which allows third parties to formally challenge the validity of a pending patent application ("pre-grant opposition"), of a granted patent ("post-grant opposition"), or of a trademark.

  5. Reexamination - Wikipedia

    en.wikipedia.org/wiki/Reexamination

    A request for a reexamination can be filed by anyone at any time during the period of enforceability of a patent. To request a reexamination, one must submit a "request for reexamination" which includes (1) a statement pointing out each "substantial new question of patentability based on prior patents and printed publications; (2) an identification and explanation for every claim for which ...

  6. MedImmune, Inc. v. Genentech, Inc. - Wikipedia

    en.wikipedia.org/wiki/MedImmune,_Inc._v...

    The case was decided in favor of MedImmune, and the United States Patent and Trademark Office (USPTO) declared the patent invalid. Genentech appealed the USPTO the ruling and the patent remained valid and enforceable until the appeal was concluded. Genentech prevailed during the reexamination of Cabilly II(2) by the USPTO (1).

  7. Qualcomm launches patent challenge to Apple ahead of ... - AOL

    www.aol.com/news/qualcomm-launches-patent...

    Qualcomm, the world's biggest maker of mobile chips, alleges in federal court in San Diego that Apple violated three of its patents, and is asking for tens of millions of dollars or more in damages.